<p>Correlation between percentage of KRAS mutation in tumor cells and disease control rate.</p
Histograms show the Spearman rank correlation coefficients between the reoccurrence frequency and mu...
<p>Correlation between percentage of tumor cells with <i>MET</i> gene copy number ≥3 and percentage ...
<p>Correlations between locations of calcifications and tumor response rate and patterns of change.<...
<p>Relationship between <i>KRAS</i> mutational status and tumoral variables measured in primary tumo...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
Evaluation of molecular tumour heterogeneity relies on the tumorous nuclei percentage (TNP) assessme...
Evaluation of molecular tumour heterogeneity relies on the tumorous nuclei percentage (TNP) assessme...
<p>The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p
<p>Correlation of NGS <i>KRAS</i> mutant allele frequency with digital PCR <i>KRAS</i> mutant allele...
<p>Relationship between Overall Survival (OS) and percentage of mutated neoplastic cells (threshold ...
<p>Associations between SEPT9 methylation rate and KRAS mutation load in tissue and plasma samples a...
<p>(A) <i>KRAS</i> shRNA activity in a panel of cancer cell lines (Project Achilles). shRNA score de...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
<p>(A) Box plot of SUV<sub>max</sub> of primary tumors according to <i>EGFR</i> and <i>KRAS</i> muta...
<p>(A) mutation rate before gland formation. (B) mutation rate after gland formation. The dashed lin...
Histograms show the Spearman rank correlation coefficients between the reoccurrence frequency and mu...
<p>Correlation between percentage of tumor cells with <i>MET</i> gene copy number ≥3 and percentage ...
<p>Correlations between locations of calcifications and tumor response rate and patterns of change.<...
<p>Relationship between <i>KRAS</i> mutational status and tumoral variables measured in primary tumo...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
Evaluation of molecular tumour heterogeneity relies on the tumorous nuclei percentage (TNP) assessme...
Evaluation of molecular tumour heterogeneity relies on the tumorous nuclei percentage (TNP) assessme...
<p>The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p
<p>Correlation of NGS <i>KRAS</i> mutant allele frequency with digital PCR <i>KRAS</i> mutant allele...
<p>Relationship between Overall Survival (OS) and percentage of mutated neoplastic cells (threshold ...
<p>Associations between SEPT9 methylation rate and KRAS mutation load in tissue and plasma samples a...
<p>(A) <i>KRAS</i> shRNA activity in a panel of cancer cell lines (Project Achilles). shRNA score de...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
<p>(A) Box plot of SUV<sub>max</sub> of primary tumors according to <i>EGFR</i> and <i>KRAS</i> muta...
<p>(A) mutation rate before gland formation. (B) mutation rate after gland formation. The dashed lin...
Histograms show the Spearman rank correlation coefficients between the reoccurrence frequency and mu...
<p>Correlation between percentage of tumor cells with <i>MET</i> gene copy number ≥3 and percentage ...
<p>Correlations between locations of calcifications and tumor response rate and patterns of change.<...